For the Inventor, By the Inventor

Enter assignee name

Shenzhen, China

Shenzhen Hightide Biopharmaceutical, Ltd.

USPTO Granted Patents = 17

CIPO Patents = 2

EPO Patents = 6

Trademarks = 3

Forward Citations = 25

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Liping Liu (16 out of 34 patents)

Ru Bai (7 out of 7 patents)

Xinxiang Fu (2 out of 2 patents)

4. Meng Yu (1 out of 27 patents)

5. Li Yu (1 out of 2 patents)

6. James Gerry Ferguson (1 out of 1 patent)

7. Meng Yu (1 out of 5 patents)

8. Liping Liu (2 patents)

17 patents: Sort by Forward Citations

1. 12138258 - Solid forms of berberine ursodeoxycholate and compositions and methods thereof (2024-11-12),

2. 11976063 - Pharmaceutical composition comprising berberine and ursodeoxycholic acid for the treatment of various diseases or disorders (2024-05-07),

3. 11883539 - Pharmaceutical compositions of berberine with EPA and DHA, and methods thereof (2024-01-30),

4. 11865106 - Methods and compositions for treatment of inflammatory bowel disease (2024-01-09),

5. 11807672 - Conjugates of islet neogenesis peptides and analogs, and methods thereof (2023-11-07),

6. 11685735 - Pharmaceutical composition comprising berberine salts for the treatment of various diseases or disorders (2023-06-27),

7. 11559531 - Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof (2023-01-24),

8. 11534477 - Use of peptide compounds in treating acute pancreatitis (2022-12-27),

9. 11369573 - Pharmaceutical compositions of berberine with EPA and DHA, and methods thereof (2022-06-28),

10. 10988471 - Pharmaceutical composition comprising berberine ursodeoxycholic acid salt for the treatment of various diseases or disorders (2021-04-27),

11. 10959999 - Solid forms of berberine ursodeoxycholate and compositions and methods thereof (2021-03-30),

12. 10899815 - Compositions and methods of using islet neogenesis peptides and analogs thereof (2021-01-26),

13. 10829527 - Conjugates of islet neogenesis peptides and analogs, and methods thereof (2020-11-10),

14. 10772929 - Use of peptide compounds in treating acute pancreatitis (2020-09-15),

15. 10301303 - Berberine salts, ursodeoxycholic salts and combinations, methods of preparation and application thereof (2019-05-28),

Shenzhen HighTide Biopharmaceutical, Ltd. is a leading biopharmaceutical company based in Shenzhen, China. We focus on the research, development, and commercialization of innovative and life-saving drugs. Our mission is to improve global healthcare by providing safe and effective therapies for various diseases. With a dedicated team of scientists and state-of-the-art facilities, we strive to discover breakthrough treatments and bring them to patients worldwide. Visit our website for more information and to explore our product portfolio.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

17 Patents

#208 in Shenzhen

#1,513 in China

#34,876 in the World

Shenzhen, China

Shenzhen Hightide Biopharmaceutical, Ltd.

Forward Citations = 25

7 inventors:

Liping Liu (16 out of 34 patents)

Ru Bai (7 out of 7 patents)

Xinxiang Fu (2 out of 2 patents)

4. Meng Yu (1 out of 27 patents)

5. Li Yu (1 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…